ClinicalTrials.govpublic full text
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
hematologic malignancies, hematologic neoplasms, chimeric-antigen-receptor t-cell therapy, high risk hematologic malignancy, cd19, hematopoietic cell transplant, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 862796
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.